Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients

J Hosp Med. 2022 May;17(5):360-363. doi: 10.1002/jhm.12798. Epub 2022 Feb 28.

Suchita Shah Sata^{1

2}, Susan E Spratt³, Daniel L Edmonston^{4

5}, Neha Pagidipati^{5

6}

¹ Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
² Duke University Hospital, Durham, North Carolina, USA.
³ Division of Endocrinology, Duke University School of Medicine, Durham, North Carolina, USA.
⁴ Division of Nephrology, Duke University School of Medicine, Durham, North Carolina, USA.
⁵ Duke Clinical Research Institute, Durham, North Carolina, USA.
⁶ Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.

No abstract available

MeSH terms